<p>Section I. Migraine Management<br>1. Non-specific analgesics, combination analgesics, and antiemetics<br>2. The 5-HT1B and 5-HT1D Agonists in Acute Migraine Therapy: Ergotamine, dihydroergotamine, and the triptans<br>3. 5-HT1F agonists<br>4. CGRP receptor antagonists (Gepants)<br>5. Preventive treatment of migraine: Non-specific oral agents<br>6. OnabotulinumtoxinA: Discussion of the evidence for effectiveness of OnabotulinumA and its place in chronic migraine treatment<br>7. CGRP monoclonal antibodies and CGRP receptor antagonists (Gepants) in migraine prevention<br>8. Nutraceuticals in migraine<br>9. Interventional treatments<br>10. Biobehavioral treatments of migraine<br>11. Physical treatment of migraine<br>12. Neuromodulation in migraine<br><br>Section II. Guidelines<br>13. Evidence-based symptomatic treatment of migraine<br>14. Evidence-based preventive treatment of migraine<br><br>Section III. Special Cases/Situations<br>15. Treatment in the emergency department<br>16. Special considerations in migraine during pregnancy and lactation<br>17. Special considerations in management of migraine in the elderly<br>18. Management of medication overuse headache<br><br>Section IV. Outcome Measures<br>19. Outcome Measures for Migraine: Measuring the impact of migraine and results of migraine treatment<br><br>Section V. Diagnosis and Treatment of Other Migraine Subtypes<br>20. Menstrually associated migraine<br>21. Hemiplegic migraine<br>22. Migraine with brainstem aura<br>23. Retinal migraine<br>24. Vestibular migraine and persistent postural perceptual dizziness<br>25. Status migrainosus<br>26. Persistent aura, visual snow, and other visual symptoms<br>27. Migrainous infarction<br>28. Migraine in children and adolescents: Assessment and diagnosis <br>29. Management of migraine in children and adolescents<br><br>Section VI. Comorbidities of Migraine<br>30. Psychiatric comorbidities of migraine<br>31. Relationship of migraine and other forms of chronic pain<br>32. Comorbidities of migraine: Sleep disorders<br>33. The evolving concept of multimorbidity and migraine<br><br>Section VII. Future Directions<br>34. Healthcare disparities faced by patients with migraine and potential mitigation strategies<br>35. Emerging and future directions of migraine research and treatment</p>
